pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
mechlorethamine hydrochloride
Valchlor (mechlorethamine hydrochloride)
Mycosis Fungoides
Helsinn Therapeutics (US) Inc
0 catalysts
Marketed
meclofenamate sodium
Meclofenamate Sodium (meclofenamate sodium)
Acute and Sub-Acute Bursitis
Mylan Pharmaceuticals Inc
0 catalysts
Marketed
mefloquine hydrochloride
Mefloquine Hydrochloride (mefloquine hydrochloride)
Malaria
Barr Laboratories Inc
0 catalysts
← prev
page 194 of 231
next →
131
Pain89
Neurology1
Marketed
megestrol acetate
Megestrol Acetate (megestrol acetate)
Anorexia Nervosa
TWi Pharmaceuticals USA Inc
0 catalysts
Marketed
meloxicam
Qamzova (meloxicam)
Post-Operative Pain
Nanjing Delova Biotech Co Ltd
0 catalysts
Marketed
melphalan
Evomela (melphalan)
Retinoblastoma
Zhaoke Ophthalmology Ltd
0 catalysts
Marketed
melphalan hydrochloride
Melblez (melphalan hydrochloride)
Bile Duct Cancer (Cholangiocarcinoma)
$DCTHDELCATH SYSTEMS, INC.
0 catalysts
Marketed
memantine hydrochloride
Memantine Hydrochloride (memantine hydrochloride)
Dementia Associated With Alzheimer's Disease
Polygen Pharmaceuticals Inc
0 catalysts
Phase 2
meningococcal (pentavalent) vaccine
MenPenta
Neisseria meningitidis Infections
$SNYSanofi
0 catalysts
Phase 3
meningococcal [serotype B] vaccine
Bexsero
Neisseria meningitidis Infections
Neisserial heparin binding antigen
$GSKGSK plc
0 catalysts
Marketed
meningococcal [serotype C] vaccine
Menomune-C
Neisseria meningitidis Infections
Sanofi Pasteur Inc
0 catalysts
Marketed
meningococcal [serotypes A, B, C, W-135, Y] vaccine
Penmenvy
Neisseria meningitidis Infections
GlaxoSmithKline LLC
0 catalysts
Marketed
meningococcal [serotypes A, C, W-135, Y] vaccine
Menveo
Neisseria meningitidis Infections
GlaxoSmithKline LLC
0 catalysts
Marketed
meningococcal [serotypes A, C, W-135, Y] vaccine (Menactra)
Menactra
Neisseria meningitidis Infections
Sanofi Pasteur Inc
0 catalysts
Preclinical
mepacrine
mepacrine [INN]
Pulmonary Arterial Hypertension
PulmoSIM Therapeutics Inc
0 catalysts
Marketed
mepenzolate bromide
Cantil (mepenzolate bromide [INN])
Peptic Ulcers
Sanofi-Aventis US LLC
0 catalysts
Marketed
mepivacaine hydrochloride
Polocaine (mepivacaine hydrochloride)
Local Anesthetic Effect
Fresenius Kabi USA LLC
0 catalysts
Phase 2
meplazumab
Ketantin
Malaria
Jiangsu Pacific Meinuoke Bio-Pharmarceutical Co Ltd
0 catalysts
Marketed
mepolizumab
Nucala (mepolizumab)
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
GlaxoSmithKline LLC
0 catalysts
Marketed
meprobamate
Meprobamate (meprobamate)
Anxiety Disorders
InvaGen Pharmaceuticals Inc
0 catalysts
Marketed
mercaptopurine
Purixan (mercaptopurine)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Rare Disease Therapeutics Inc
0 catalysts
Phase 1
meropenem + pilabactam
meropenem [INN] + pilabactam [INN]
Acinetobacter Infections
Antabio SAS
0 catalysts
Phase 3
mesdopetam
mesdopetam [INN]
Drug-Induced Dyskinesia
IRLAB Therapeutics AB
0 catalysts
Marketed
metamfetamine
Desoxyn (metamfetamine [INN])
Attention Deficit Hyperactivity Disorder (ADHD)
Recordati Rare Diseases Inc
0 catalysts
Marketed
metaproterenol sulfate
Metaproterenol Sulfate (metaproterenol sulfate)
Asthma
Chartwell Pharmaceuticals LLC
0 catalysts
Marketed
metaraminol
Metaraminol Bitartrate (metaraminol [INN])
Hypotension
Slayback Pharma LLC
0 catalysts
Phase 1
metarrestin
Breast Cancer
U.S. National Institutes of Health
0 catalysts
Marketed
metaxalone
Metaxalone Corepharma (metaxalone)
Myalgia (Muscle Pain)
CorePharma LLC
0 catalysts
Preclinical
methanobactin
Wilson Disease
Arbormed Co Ltd
0 catalysts
Marketed
methenamine hippurate
methenamine hippurate Leading Pharma (methenamine hippurate)
Urinary Tract Infections
Leading Pharma LLC
0 catalysts